Anxiety disorders are a set of related mental conditions that include: generalized anxiety disorder, panic disorder, obsessive-compulsive disorder (OCD), posttraumatic stress disorder (PTSD), social phobia, and simple phobias. Anxiety disorders are treated by a combination of psychiatric medications and psychotherapy.
This report contains market size and forecasts of Anxiety Disorders Treatment in Global, including the following market information:
Global Anxiety Disorders Treatment Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global top five companies in 2021 (%)
The global Anxiety Disorders Treatment market was valued at 6889.4 million in 2021 and is projected to reach US$ 7433.1 million by 2028, at a CAGR of 1.1% during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Self-treatment Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Anxiety Disorders Treatment include Limbix, DarioHealth, Holmusk, Omada Health, Express Scripts, Click Therapeutics, Akili Interactive, Pear Therapeutics and Iora Health, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Anxiety Disorders Treatment companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Anxiety Disorders Treatment Market, by Type, 2017-2022, 2023-2028 ($ millions)
Global Anxiety Disorders Treatment Market Segment Percentages, by Type, 2021 (%)
Self-treatment
Psy-treatment
Medications
Global Anxiety Disorders Treatment Market, by Application, 2017-2022, 2023-2028 ($ millions)
Global Anxiety Disorders Treatment Market Segment Percentages, by Application, 2021 (%)
Major Depressive Disorder (MDD)
Obsessive-Compulsive Disorder (OCD)
Phobia
Others
Global Anxiety Disorders Treatment Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)
Global Anxiety Disorders Treatment Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Anxiety Disorders Treatment revenues in global market, 2017-2022 (estimated), ($ millions)
Key companies Anxiety Disorders Treatment revenues share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Limbix
DarioHealth
Holmusk
Omada Health
Express Scripts
Click Therapeutics
Akili Interactive
Pear Therapeutics
Iora Health
Quartet Health
AbleTo
Ginger.io
Joyable
Headspace
Akili Interactive Labs
Medsphere Systems
Rivermend Health
Lyra Health
Happify